ClinicalTrials.govpublic full text
Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration
age-related wet macular degeneration, age-related macular degeneration, macular degeneration, wamd, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 800185
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.